# Treating Rheumatoid Arthritis With Tripterygium Wilfordi Hook F or Sulfasalazine

> **NCT00062465** · PHASE2 · COMPLETED · sponsor: **National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)** · enrollment: 157 (—)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** TwHF

## Key facts

- **NCT ID:** NCT00062465
- **Lead sponsor:** National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-06
- **Primary completion:** —
- **Final completion:** 2006-03
- **Target enrollment:** 157 (—)
- **Last updated:** 2008-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00062465

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00062465, "Treating Rheumatoid Arthritis With Tripterygium Wilfordi Hook F or Sulfasalazine". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00062465. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*